Endotoxin induces a variety of proinflammatory mediators and plays a crucial role in kidney inflammation. The receptor tyrosine kinase, Mer, diminishes renal inflammation by attenuating inflammatory responses. We previously reported that Mer is predominantly expressed on glomerular endothelial cells (GECs) and that Mer deficiency is associated with increased renal inflammation when mice are challenged with nephrotoxic serum. We consequently hypothesized that Mer signaling down-regulates LPS-driven inflammatory responses in GECs. To test this hypothesis, primary GECs were isolated from the kidneys of Mer-KO and wild-type (WT) control mice. LPS treatment induced Akt and STAT3 activation along with Bcl-xl up-regulation in WT GECs; these responses were all increased in Mer-deficient GECs. In addition, STAT1 and ERK1/2 up-regulation and activation were observed in Mer-KO GECs exposed to LPS. In contrast, expression of the inhibitory signaling molecule, suppressor of cytokine signaling-3 (SOCS-3), was much higher in LPS-stimulated WT than Mer-deficient GECs. Deficiency of Mer was also associated with significantly increased NF-B expression and activation. These observations indicate that Mer functions as an intrinsic feedback inhibitor of inflammatory mediator-driven immune responses in GECs during kidney injury and suggest a new therapeutic strategy for glomerular diseases.
INTRODUCTION
Glomerulonephritis (GN) encompasses a group of immune-mediated disorders that cause inflammation within the glomerulus and other compartments in the kidney. GN remains a leading cause of end-stage renal disease, yet treatment is still very limited. 1,2 GN pathogenesis is also complex. Glomerular endothelial cells (GECs) have an active role in the glomerular response to injury. 3 Altered GEC function has been associated with increased leukocyte recruitment and increased angiogenesis. GEC injury was commonly present in a cohort of type 2 diabetes patients with macroalbuminuria and GEC abnormalities were more closely associated with increasing urine albumin excretion. 4 GECs express a subset of TLRs and can respond to intrinsic damageassociated molecular patterns. 5 However, the mechanism by which GEC dysfunction results in albuminuria is poorly understood.
Abbreviations: GEC, glomerular endothelial cell; GN, glomerulonephritis; MCP-1, monocyte chemotactic protein-1; NTS, nephrotoxic serum; SOCS, suppressor of cytokine signaling; TAM, Tyro-3, Axl, and Mer TAM (Tyro-3, Axl, and Mer) receptor tyrosine kinases are essential regulators of immune homeostasis that dampen the activation of immune cells and restore tissue function by promoting tissue repair and clearance of apoptotic cells. [6] [7] [8] TAM-dependent pathways act as a negative feedback mechanism that suppresses inflammation. 7 Consistent with this, deficient TAM signaling has been linked to the pathogenesis of autoimmune, inflammatory, and infectious diseases. [9] [10] [11] One of the TAM receptor tyrosine kinases, Mer, has been particularly associated with an anti-inflammatory effect. Mer signaling participates in a novel inhibitory pathway in TLR activation [12] [13] [14] and a Mer signaling pathway in macrophages that involves PI3K/Akt and NF-B down-regulates proinflammatory signals. 15, 16 In addition, Mer-KO mice have been shown to be hypersensitive to LPS. 17 Our previous work showed that Mer down-regulates renal inflammation, with consequent increased susceptibility to anti-glomerular basement membrane mediated kidney damage in Mer-deficient mice. 18, 19 Consistent with this, Mer is highly expressed in the glomerulus and is upregulated upon kidney inflammation. 18, 20 However, the molecular basis of the Mer-mediated signaling pathway involved in down-regulation of inflammatory responses in GECs has not been established.
In the present study, we extend our previous work by investigating the inhibitory role of Mer on LPS-induced inflammatory signaling pathways in GECs. After defining the expression pattern of Mer on cell subsets in mouse kidney, we compared LPS signaling in isolated primary GECs from wild-type (WT) and Mer-deficient mice. Results of these studies provide a mechanism for the anti-inflammatory effects of Mer by showing strong Mer expression in GECs that is upregulated by LPS, as well as increased STAT1, STAT3, Akt, Bcl-2, and ERK1/2 expression and activation and decreased suppressor of cytokine signaling 3 (SOCS-3) expression in GECs in the absence of Mer.
MATERIALS AND METHODS

Animals and reagents
WT and Mer-KO mice on a C57BL/6 background were housed under specific pathogen-free conditions at the animal facilities of the University of Cincinnati. All animal experiments were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee.
LPS (Escherichia coli LPS, 055:B5) was purchased from Sigma Aldrich (St. Louis, MO). The Abs used in this study were all purchased from Cell Signaling Technology (Boston, MA), unless otherwise stated in the text.
Immunofluorescent staining
Mouse kidneys were snap-frozen in liquid nitrogen. Sections (4 m) were fixed in methanol and blocked with 5% BSA. Anti-mouse Abs (1:100 dilution) were added and incubated with sections. Secondary Abs were added after wash as indicated in the figure legends. Images were acquired using a Nikon E1000 fluorescent microscope (Melville, NY) equipped with camera and analyzed with a bioquantification software system (Bioquant TCW 98, Nashville, TN).
Flow cytometry
Renal cortex of kidney samples was isolated from healthy WT and Mer-KO mice. Single cell suspensions were obtained as previously described. 18 Cells were then incubated with Fc blocker (2.4G2) for 
Isolation and culture of primary GECs
Mer-KO mice were first genotypically confirmed by conventional PCR using whole tail lysate (Fig. 1A) . 17 Whole kidneys from healthy WT and Mer-KO mice were then surgically removed under sterile conditions. Primary GECs were isolated and prepared to achieve 95-99% purity at the Cell Biologics (Chicago, IL). Cells were then aliquoted and stored in liquid nitrogen. Tissue culture flasks and plates were coated with gelatin at 37 • C for 1 h. GECs were cultured in the endothelial basal medium supplied by Cell Biologics. Mer deficiency in GECs was further confirmed by Western Blot (Fig. 1A) . For LPS treatment experiments, GECs were cultured in 6-well plates 1 day before stimulation at a density of 0.5 × 10 6 cells per well. Cells were washed once with fresh medium the next day and a range of concentrations of LPS was added. Three days later, cells were harvested for Western blot analysis. Culture supernatants were centrifuged for 20 min at 15,000 rpm to remove debris and stored at -80 • C.
Protein array analysis
The cytokine profile of GECs stimulated with LPS was measured using the Proteome Profiler Array from R&D Systems according to the manufacturer's guidelines. In brief, cell culture supernatants were centrifuged to remove particles. A mouse cytokine array membrane was blocked for 1 h at room temperature and incubated with a detecting Ab/sample mix overnight at 4 • C. The membrane was then washed and incubated with streptavidin-HRP. Cytokine protein levels were visualized with Chemi Reagent Mix. 
Western blotting
Statistics
Western blot data were analyzed using ImageJ software (NIH, Bethesda, MD). Intensity differences between groups were tested using the Mann-Whitney U test. Data are shown as median with interquartile range. All statistical analyses were carried out using Microsoft Excel or Prism software (GraphPad, San Diego, CA). Results were considered significant at *P < 0.05, **P < 0.01, ***P < 0.001.
RESULTS
Mer is primarily expressed on GECs
We previously reported that Mer protects against renal inflammation. 18, 19 Consistent with this, renal Mer expression, which was originally demonstrated by Northern blot, 20, 21 is highest in both mice and humans in the kidney. [19] [20] [21] We confirmed renal expression of Mer protein by Western blot 19 and immunofluorescent F I G U R E 1 Mer is expressed in mouse glomeruli. (A) Mouse tail lysate was obtained and genotyping PCR was performed as previously described. 17 Western blotting (WB) analysis of Mer expression on primary GECs was also performed (bottom row). (B) Kidney sections (4 m) obtained from C57BL/6 mice were stained with biotin-conjugated anti-mouse Mer and visualized with PE-streptavidin. Glomerular cell subsets were stained with specific markers as indicated in the figure. (C) Kidneys from B6.WT and B6.Mer-KO mice were cut into < 1 mm pieces and subjected to collagenase I and DNase digestion. After EDTA incubation, single cell suspensions were stained for specific markers. Neutrophils were gated for Gr-1 and CD11b double positivity; macrophages were gated on CD11b + and Gr-1 − populations; glomerular mesangial cells, endothelial cells, and podocytes were gated according to surface antigens, as described in Methods section. (D) Kidney sections were obtained from WT and nephrotoxic serum (NTS) injected mice 19 and stained with anti-Mer and anti-CD31 antibodies. Data are representative of 2 repeats. **P < 0.01 staining (Fig. 1B) . We also stained a single cell suspension of kidney cells with Abs that are specific for renal cell subtypes and identified GECs as the primary Mer-bearing cells (Fig. 1C) . Kidney resident macrophages also expressed low levels of surface Mer (Fig. 1C) .
Increased Mer expression was previously reported in the kidney of nephritic mice as compared to the kidney of control mice. 18 Figure 1D shows that glomerular Mer continues to be predominantly expressed by endothelial cells following treatment of mice with nephrotoxic serum (NTS).
Mer inhibits LPS-induced expression and activation of Akt and ERK1/2 in GECs
LPS induces proliferation and survival through expression and activation of Akt and ERK1/2 in many cells, including endothelial cells. 22 Although TAM receptors inhibit LPS-induced signals, 8 the ability of Mer to directly inhibit LPS signaling in GECs has not been studied. To address this, we studied the effects of LPS 72 h postincubation, which is the time of maximal LPS-induced cellular activation. 23 LPS increased total and phosphorylated Akt protein in WT primary GECs; however, this was seen to a considerably greater extent in Mer-deficient than in WT GECs ( Figs. 2A and B) . Total and phospho-ERK were both considerably increased in Mer-deficient GECs, but were not significantly increased in WT GECs (Figs. 2C and D) . Consistent with our previous findings, 19 p38MAP kinase remained undetectable in primary GECs regardless of Mer expression (data not shown). Taken together, these data suggest an inhibitory function of Mer in regulating LPS-mediated Akt and ERK1/2 expression and activation.
Mer suppresses LPS-induced Bcl expression
LPS-induced TLR4 activation triggers increased expression of cell survival genes, including Bcl family proteins. 24 Baseline Bcl-2 levels were significantly higher in Mer-deficient than in WT GECs and F I G U R E 2 Mer inhibits LPS-induced Akt and ERK1/2 expression and phosphorylation. Primary GECs were isolated as described in Methods section. WT and Mer-KO GECs were cultured in 6-well plates at a density of 0.5 × 10 6 cells per well overnight. GECs were then treated with a range of concentrations of LPS for 3 days. Cells were then lysed and the LPS-downstream signaling proteins, Akt (A) and ERK1/2 (C), and their phosphorylated forms (B and D) were analyzed by Western blotting with specific antibodies. (E) Loading controls ( -actin). Experiments were repeated independently at least 3 times. Densitometry analyses to quantify the intensity of the indicated proteins are shown. Representative blots were shown below each bar graph. Values are the median and interquartile range. The Mann-Whitney U test was used to determine statistical significance. *P < 0.05, **P < 0.01. ***P < 0.001, Mer-KO LPS treated versus untreated; ## P < 0.01, WT LPS versus WT untreated were increased by LPS stimulation to a relatively small, but significant extent in both (Figs. 3A and B) . Increased baseline level of Bcl-2 expression in the Mer-deficient GECs may reflect a surveillance function of Mer on GECs to keep GECs quiescent under pressure and constant contact with stimuli, such as cell debris and immunoglobulin. A surveillance function of Mer on GECs may also explain the maintenance of a higher level of Mer on GECs. Baseline Bcl-6 levels were also higher in Mer-deficient than in WT GECs and did not increase in response to LPS; in fact, relatively low, but not for high doses of LPS in the Mer-deficient GECs (Figs. 3A and C) . In contrast, baseline Bcl-xl levels were lower in Mer-deficient than in WT GECs, but increased to a greater extent in the Mer-deficient than in the WT cells in response to high levels of LPS, so that Bclxl levels in LPS-stimulated WT and Bcl-xl GECs were comparable (Figs. 3A and D) .
Mer-mediated suppression is associated with SOCS up-regulation and STAT and NF-B down-regulation
In macrophages, Mer signaling suppresses LPS-induced STAT1 activation by increasing SOCS-1 and SOCS-3 protein synthesis. 25 We explored this pathway in mouse GECs by quantitating total SOCS and STAT proteins and phosphorylated STAT proteins. Indeed, Mer deficiency increased baseline total STAT1 and STAT3 levels; these levels were not increased or only modestly increased by LPS stimulation (Figs. 4A, B, and D) . Baseline levels of activated (phospho) STAT1 and STAT3 were relatively unaffected by Mer deficiency, but less LPS was required to increase STAT3 activation in Mer-deficient than in WT GECs (Figs. 4A and C) and LPS only increased STAT1 activation in the Mer-deficient cells (Figs. 4A and E) .
F I G U R E 3
Enhanced Bcl-2 expression in Mer-KO GECs. Primary GECs were prepared, cultured, and LPS treated as in Fig. 2 . Bcl-2, Bcl-6, and Bclxl expression was analyzed by Western immunoblotting. Representative blots were shown in (A). Total amounts of protein loading were indicated by -actin. Experiments were repeated independently at least 3 times. Densitometry analyses to quantify the intensity of the indicated proteins are shown in (B-D). Values are the median and interquartile range. The Mann-Whitney U test was used to determine statistical significance. *P < 0.05, **P < 0.01, Mer-KO LPS treated versus untreated; # P < 0.05, WT LPS versus WT untreated Rothlin et al. revealed a SOCS-mediated STAT inhibitory pathway in macrophages that was deficient when all 3 TAM receptors were absent. 8 We hypothesized that Mer suppression of STAT activation in GECs might similarly be due to SOCs proteins. Consistent with this hypothesis, much greater expression of SOCS-3 was detected in LPStreated WT than Mer-deficient GECs; even the smallest dose of LPS tested was sufficient to elicit this difference (Fig. 5) . SOCS-1 expression was not detected in any samples studied (data not shown). Taken together, the data shown here are consistent with the hypothesis that Mer suppresses LPS-induced STAT1/3 activation, at least in part, by activating SOCS-3.
TAM kinases were reported to suppress the effect of LPS by targeting the PI3K/Akt pathway, leading to the inhibition of NF-B. 26, 27 To investigate whether Mer-mediated inhibitory pathway involves NF-B activation in the GECs, we measured expression levels of the NF-B P65 subunit in cell lysates and compared levels of the activated/phosphorylated subunit in WT and Mer-KO GECs. A significantly decreased level of NF-B P65 activation was revealed in the WT GECs as compared to similarly treated Mer-KO GECs (Fig. 5B ). Similar to Bcl-2 and Bcl-6 expression (Fig. 3) , baseline level of NF-B expression and activation in the Mer-deficient GECs were also increased (Fig. 5B) . Data presented here reflect a central role for Mer in inhibiting kidney inflammation.
Mer decreases secretion of some cytokines and chemokines by LPS-stimulated GECs
Mer deficiency in mice results in significantly enhanced cytokine and chemokine expression in the kidney when experimental nephritis is induced. 18 To investigate whether some of these cytokines/chemokines are directly regulated by Mer-expressing GECs, a Proteome Profiler array was employed that measured the levels of 40 cytokines and chemokines secreted into a GEC culture supernatant. Ten cytokines and chemokines were upregulated by LPS in GECs, and Mer disruption significantly modulated 3 of them (Fig. 6A) . Monocyte chemotactic protein-1 (MCP-1) is an important regulator of monocyte/macrophages migration and infiltration. 28 Surprisingly, LPS activation significantly decreased GEC MCP-1 secretion (Fig. 6B) . However, there was significantly less of a decrease in Mer-deficient than in WT LPS-stimulated GECs. (Fig. 6B) . CXCL-1 (also known as KC in mice) plays a pivotal role in recruiting and activating neutrophils at tissue sites. 29 This is relevant because we observed considerable neutrophil infiltration in the kidneys of nephritic Mer-KO mice. 18 Here, we confirmed our previous observation that LPS stimulation significantly enhances CXCL-1 secretion by GECs. The amount of CXCL-1 secreted tended to be slightly higher with LPSstimulated Mer-deficient than WT GECs (Fig. 6C ), but the difference F I G U R E 4 Mer inhibits STAT expression and phosphorylation in LPS-treated GECs. Primary GECs were prepared, cultured, and LPS treated as in Fig. 2 . STAT1 and STAT3 expression and phosphorylation were analyzed by Western immunoblotting. Representative blots were shown in (A). Experiments were repeated independently at least 3 times. Densitometry analyses to quantify the intensity of total STAT1 and STAT3 are shown in (B) and (C). Values are the median and interquartile range. The Mann-Whitney U test was used to determine statistical significance. *P < 0.05, **P < 0.01, Mer-KO LPS treated versus untreated; ## P < 0.01, ### P < 0.001, WT LPS versus WT untreated was not statistically significant at the LPS dose tested. M-CSF can stimulate macrophage proliferation and cytokine secretion. Endothelial cells activated by LPS are known to secrete M-CSF. 30 Although LPS-stimulated WT and Mer-KO GECs both secreted considerable M-CSF, over twice as much was secreted by the Mer-deficient cells (Fig. 6D) . LPS also induced a marked increase in IL-6 secretion, which was not affected by Mer deficiency at the LPS dose tested (Fig. 6E ).
DISCUSSION
Our previous in vivo data provided evidence of Mer expression and activation in the kidney before and after NTS injection, respectively. 18, 19 Moreover, these data suggested that Mer is a feedback inhibitor of inflammation-driven immune response during nephritis. 19 Observations that Mer mRNA and protein expression are highest in the kidney suggested that Mer might contribute importantly to homeostasis and protection from inflammation in this organ. 20, 21 In this study, we identified GECs as the principal Mer expressing cells in the kidney. Previously, the immuoregulatory role of Mer has been mainly studied in macrophages and dendritic cells, [31] [32] [33] [34] [35] although Mer has been reported to have a negative regulatory effect on LPS-induced lung inflammation. 12 To our knowledge, ours is the first evidence of intrinsic Mer regulation of inflammation associated with GECs.
TAM-dependent pathways lie at the intersection of the innate and the adaptive immune systems, where they provide inhibitory feedback that is required to dampen inflammation. 8 The loss of function of these 3 receptors results in a broad-spectrum autoimmune disease with lymphocyte infiltration into all tissues. 10 Although most immunological phenotypes are visible or exacerbated only when all 3 receptors are simultaneously ablated, 6 a unique deficiency in Mer, but neither of the other TAM receptors, is sufficient to induce autoimmune disease. 9 The essential role of TAM kinase activation in dampening (Fig. 5) . STAT3 activation in macrophages is largely negatively regulated by intracellular levels of SOCS3. Our data support this notion, in which an association between SOCS3 upregulation and STAT1/3 down-regulation was observed in the WT GECs. Mer-KO mice died from sublethal dose of LPS due to cytokine storm (mainly TNF-), indicating a suppressive role of Mer in mediating inflammatory cytokine production. 17 The increased TNF-production was associated with increased NF-B activity. 17 The suppressive role of Mer in LPS-induced inflammatory responses also involves the inhibition of NF-B (Fig. 5B) . NF-B was found to increase Bcl-2 transcription 10-fold. 36 Decreased Bcl-2 in WT GECs incubated with LPS may be a result of Mer-mediated NF-B inhibition. Taken together, Mer-mediated inhibition of NF-B may down-regulate several signaling molecules, including TNF-, Bcl-2, and Bcl-xl. The net effect of Mermediated inhibition may depend on the cell type and stimulus involved.
High Mer expression on GECs may be one mechanism that allows these cells to suppress inflammation. This is essential, inasmuch as GECs are key components of the glomerular filtration unit that is critical for maintaining glomerular basement membrane integrity, 
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